Flublok Approval History
- FDA approved: Yes (First approved January 16th, 2013)
- Brand name: Flublok
- Generic name: influenza vaccine
- Dosage form: Injection
- Company: Protein Sciences Corp.
- Treatment for: Influenza Prophylaxis
Flublok (influenza vaccine, recombinant hemagglutinin) is an influenza vaccine indicated for active immunization against seasonal influenza in adults 18 years of age and older .
Flublok is manufactured using modern cell culture technology, and does not contain any preservatives (e.g., thimerosal, which contains mercury), egg proteins, gelatin or latex.
Flublok is administered via intramuscular (IM) injection annually prior to flu season. The most commonly reported side effect is pain at the injection site. Headache, fatigue or muscle aches may also occur.
Development History and FDA Approval Process for Flublok
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.